EUVIMEDEUVIMED entdecken
Crossref

Autosomal dominant tubulointerstitial kidney disease in Chinese patients

Meng-Shi Li, Lei Jiang, Rui-Lian You iD, Zhi-Ying Liu, Yang Li, Xin Wang, Zhuo-Ran Song, Bin Wang iD, Yu-Qing Chen, Ji-Cheng Lv, Li Yang iD, Hong Zhang und 1 weitere

Nephrology Dialysis Transplantation · 29.05.2026 · 41 (6) · 1045-1057

DOI: 10.1093/ndt/gfaf229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 27.10.2025. Verfasst von Meng-Shi Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital; Kidney Genetics Center, Peking University Institute of Nephrology; Peking University Institute of N…. Hauptthemen laut MEDLINE: Biomarkers, Hepatocyte Nuclear Factor 1-beta, Nephritis, Interstitial, Polycystic Kidney, Autosomal Dominant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Science Foundation of China, Beijing Nova Program Interdisciplinary Cooperation Project, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is recognized as a significant cause of genetic kidney disease. However, data from Asian populations remain limited.

Methods

We evaluated 70 patients meeting KDIGO clinical criteria for ADTKD at Peking University First Hospital between 2010 and 2024. Genetic testing was performed using whole-exome sequencing, with PacBio long-read sequencing employed for cases meeting clinical criteria but lacking identifiable causal variants. Plasma and urinary uromodulin levels were measured and compared between ADTKD, IgA nephropathy, and polycystic kidney disease patients.

Results

In this Chinese cohort of 70 ADTKD patients, ADTKD-UMOD was the most prevalent subtype, accounting for 51% of cases, followed by ADTKD-HNF1B (23%), ADTKD-MUC1 (20%), and ADTKD-REN (6%). A notable 71% of patients had a family history of chronic kidney disease, with de novo variants present in 50% of ADTKD-HNF1B cases. The mean age at diagnosis was 32 ± 11 years, and patients exhibited an average estimated glomerular filtration rate (eGFR) of 46 ± 21 ml/min/1.73 m². Importantly, uromodulin levels proved to be a highly effective biomarker, distinguishing ADTKD-UMOD from other subtypes and kidney diseases with impressive diagnostic accuracy, achieving area under the curve values of 0.85 for plasma, 0.86 for urine, and 0.93 when combined.

Conclusion

This study establishes the first ADTKD cohort in China, revealing distinctive genetic and clinical features, including a high prevalence of UMOD and HNF1B variants. Urine and plasma uromodulin proved to be reliable biomarkers for diagnosing and monitoring ADTKD-UMOD. Incorporating uromodulin testing into clinical practice may improve early diagnosis and management of ADTKD and related kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHepatocyte Nuclear Factor 1-betaNephritis, InterstitialPolycystic Kidney, Autosomal DominantUromodulinAdultFemaleHumansMaleMiddle AgedChinaFollow-Up StudiesGlomerular Filtration RateKidney Function TestsMucin-1PrognosisEast Asian People

Stichwörter der Autor:innen

HNF1BMUC1UMODautosomal dominant tubulointerstitial kidney diseasebiomarker

Substanzen

BiomarkersHepatocyte Nuclear Factor 1-betaHNF1B protein, humanMUC1 protein, humanMucin-1UMOD protein, humanUromodulin

Autor:innen und Institutionen

  • Renal Division, Peking University First Hospital; Kidney Genetics Center, Peking University Institute of Nephrology; Peking University Institute of Nephrology, Key Laboratory of Renal Disease, National Health Commission…
  • Department of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China.

ORCID-Profile: Rui-Lian You, Bin Wang, Li Yang

Förderung

  • National Science Foundation of China
  • Beijing Nova Program Interdisciplinary Cooperation Project
  • National High Level Hospital Clinical Research Funding
  • Chinese Academy of Medical Sciences
  • China International Medical Foundation
  • Beijing Bethune Charitable Foundation

Zitieren

APA

Li, M. S., Jiang, L., You, R. L., Liu, Z. Y., Li, Y., Wang, X., Song, Z. R., Wang, B., Chen, Y. Q., Lv, J. C., Yang, L., Zhang, H., & Zhou, X. J. (2026). Autosomal dominant tubulointerstitial kidney disease in Chinese patients. Nephrology Dialysis Transplantation, 41(6), 1045-1057. https://doi.org/10.1093/ndt/gfaf229

Vancouver

Li MS, Jiang L, You RL, Liu ZY, Li Y, Wang X, et al. Autosomal dominant tubulointerstitial kidney disease in Chinese patients. Nephrology Dialysis Transplantation. 2026;41(6):1045-1057. doi:10.1093/ndt/gfaf229

BibTeX
@article{Li2026,
  author = {Li, Meng-Shi and Jiang, Lei and You, Rui-Lian and Liu, Zhi-Ying and Li, Yang and Wang, Xin and Song, Zhuo-Ran and Wang, Bin and Chen, Yu-Qing and Lv, Ji-Cheng and Yang, Li and Zhang, Hong and Zhou, Xu-Jie},
  title = {Autosomal dominant tubulointerstitial kidney disease in Chinese patients},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {6},
  pages = {1045--1057},
  doi = {10.1093/ndt/gfaf229}
}
Kostenlos starten →